| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,835 | 7,371 | 7,256 | 7,169 | | Cost of Revenue | 2,249 | 2,368 | 2,471 | 2,345 | | | Gross Profit | 5,586 | 5,003 | 4,785 | 4,824 | | | Operating Expenses | | Research Development | 1,760 | 1,747 | 1,731 | 1,642 | | Selling General and Administrative | 4,557 | 5,228 | 4,644 | 4,377 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (731) | (1,972) | (1,590) | (1,195) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 35 | 73 | 68 | 171 | | Earnings Before Interest And Taxes | (696) | (1,899) | (1,522) | (1,024) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (696) | (1,899) | (1,522) | (1,024) | | Income Tax Expense | (39) | 26 | 20 | (145) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (657) | (1,925) | (1,542) | (879) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (657) | (1,925) | (1,542) | (879) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($657) | ($1,925) | ($1,542) | ($879) |
|
0.50% Nasdaq 
0.05 (2.92%) 
Income Statement
